Literature DB >> 31834507

The role of radiological and hybrid imaging for muscle metastases: a systematic review.

Amalia Lupi1, Michael Weber2, Paolo Del Fiore3, Marco Rastrelli3, Giuseppe Guglielmi4, Roberto Stramare1, Emilio Quaia1, Diego Cecchin5, Chiara Giraudo6.   

Abstract

AIM OF THE STUDY: Skeletal muscle metastases (SMM) are a rare entity, mainly detected at autopsy. Nevertheless, radiological and nuclear medicine imaging can contribute to the diagnosis with a significant impact on the treatment and prognosis of neoplastic patients. This study aimed to systematically review the features of SMM at imaging considering the primary tumors and the sites of occurrence.
MATERIALS AND METHODS: We conducted a systematic search of three electronic database (i.e., PubMed, Science Direct, and Web of Science) up to May 2019, without any language or time interval restriction. Two reviewers performed the search and selection process, data extraction, and synthesis. We resolved disagreements by consensus and/or involving a third reviewer. The included studies have been classified according to the Oxford Centre for Evidence Based Medicine (CEBM) grading system.
RESULTS: Out of 8598 and 1077 articles respectively for radiological and hybrid imaging, 29 papers were included. According to CEBM, twelve were level 4. Computed tomography (CT) is mainly applied and, despite the existence of CT and magnetic resonance-based classifications, these are rarely used. Positron emission tomography/CT allowed the detection of small and subtle lesion also in the extremities. Muscles of the trunk were mostly affected and mainly respiratory tumors are associated with this type of metastatic spread.
CONCLUSION: Radiological and hybrid imaging allow a precise characterization of SMM. However, a more systematic approach, including also the application of available classification systems, may increase the diagnostic accuracy for this rare type of metastases. KEY POINTS: • Skeletal muscle metastases have heterogeneous characteristics at imaging but mostly abscess-like features and high metabolic activity are described. • Skeletal muscle metastases mainly affect the muscles of the trunk. • Pulmonary, urological, and gastrointestinal cancers are the most frequent cause of skeletal muscle metastases.

Entities:  

Keywords:  Magnetic resonance; Metastasis; Multislice computed tomography; Muscles; Positron emission tomography-computed tomography

Mesh:

Year:  2019        PMID: 31834507     DOI: 10.1007/s00330-019-06555-4

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  43 in total

Review 1.  Carcinoid tumor metastases to the extraocular muscles: MR imaging and CT findings and review of the literature.

Authors:  A Gupta; J L Chazen; C D Phillips
Journal:  AJNR Am J Neuroradiol       Date:  2011-06-09       Impact factor: 3.825

Review 2.  Intramuscular metastases on FDG PET-CT: a review of the literature.

Authors:  Jasper Emmering; Wouter V Vogel; Marcel P M Stokkel
Journal:  Nucl Med Commun       Date:  2012-02       Impact factor: 1.690

3.  Comparison of ADC values in different malignancies of the skeletal musculature: a multicentric analysis.

Authors:  Alexey Surov; Shuji Nagata; Ahmed A Abd Razek; Sree Harsha Tirumani; Andreas Wienke; Thomas Kahn
Journal:  Skeletal Radiol       Date:  2015-04-28       Impact factor: 2.199

4.  Skeletal muscle metastases from breast cancer: two case reports.

Authors:  Young Woo Kim; Kyung Jin Seo; Su Lim Lee; Ki Wook Kwon; Joon Hur; Ho Jung An; Yoon Ho Ko; Jeong Soo Kim; Hye Sung Won
Journal:  J Breast Cancer       Date:  2013-03-31       Impact factor: 3.588

5.  Imaging of the skeletal muscle metastases.

Authors:  T Arpaci; G Ugurluer; T Akbas; R B Arpaci; M Serin
Journal:  Eur Rev Med Pharmacol Sci       Date:  2012-12       Impact factor: 3.507

6.  CT detection of skeletal muscle metastases.

Authors:  S R Schultz; R L Bree; R E Schwab; G Raiss
Journal:  J Comput Assist Tomogr       Date:  1986 Jan-Feb       Impact factor: 1.826

7.  Skeletal muscle metastases from lung cancer.

Authors:  K S Sridhar; R K Rao; B Kunhardt
Journal:  Cancer       Date:  1987-04-15       Impact factor: 6.860

8.  Clinical value of whole-body magnetic resonance imaging in health screening of general adult population.

Authors:  David Laszlo Tarnoki; Adam Domonkos Tarnoki; Antje Richter; Kinga Karlinger; Viktor Berczi; Dirk Pickuth
Journal:  Radiol Oncol       Date:  2015-03-03       Impact factor: 2.991

9.  18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.

Authors:  Chiara Giraudo; Markus Raderer; Georgios Karanikas; Michael Weber; Barbara Kiesewetter; Werner Dolak; Ingrid Simonitsch-Klupp; Marius E Mayerhoefer
Journal:  Invest Radiol       Date:  2016-03       Impact factor: 6.016

10.  Haematogenous muscular metastasis of non-small cell lung cancer in F-18 fluorodeoxyglucose positron emission tomography/computed tomography.

Authors:  Karyagar Savas; Koc Zehra Pinar; Karyagar Saglampinar Sevda; Kesici Ugur; Savli Evrim; Cinarka Halit; Mungan Sevdegul; Balci Tansel Ansal
Journal:  Contemp Oncol (Pozn)       Date:  2014-10-18
View more
  3 in total

1.  Pancreatic Cancer with a Skeletal Muscle Metastasis-A Case Presentation and Literature Review.

Authors:  Nicholas Spetsieris; Gayatri Bobba; Priyanka Bhandari; Samir Patel; Zubin Tharayil; Ravi Gupta
Journal:  J Community Hosp Intern Med Perspect       Date:  2022-09-09

2.  EML4-ALK positive lung adenocarcinoma with skeletal muscle metastasis in the right calf which was treatable with lorlatinib after resistance to treatment with alectinib.

Authors:  Hironari Matsuda; Munechika Hara; Shin-Ichiro Iwakami; Kazuhisa Takahashi
Journal:  BMJ Case Rep       Date:  2021-04-27

3.  Masseter Muscle Metastasis of Renal Cell Carcinoma: A Case Report and Literature Review.

Authors:  Fei Qin; Xiaofei Zhang; Jie Zhang; Shuaihong Liu; Zijie Wang; Fei Xie; Mingxin Zhang; Tianwei Zhang; Shuangyi Wang; Wei Jiao
Journal:  Front Oncol       Date:  2022-02-02       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.